RBCC: New Innovations Spur Demand for 3D Printing in Medicine

MIRAMAR BEACH, Fla. — (BUSINESS WIRE) — February 20, 2014 — As Rainbow Coral Corp. (OTCBB: RBCC) works to market and develop an innovative new 3D bioprinting system, new 3D printing innovations are generating massive new demand for the technology from patients and doctors alike in the medical industry.

Just days ago, it was reported worldwide that a British surgeon successfully used the latest 3D printing techniques to create a new pelvis for a man who had lost half of his own to bone cancer. It was the first, groundbreaking transplant of its kind, but hardly the only medical breakthrough to arise through 3D printing.

The revolutionary technology is moving the entire healthcare sector forward. 3D printers have been used to create prosthetic limbs, custom hearing aids and even human tissues.

RBCC is well-positioned to capitalize on the rise of 3D printing in medicine thanks to its joint venture with Nano3D Biosciences (n3D). The companies have teamed up to market and develop the BiO Assay, the first commercially available 3D bioprinter designed specifically for rapid, high-volume drug screening.

The automated toxicity assay uses biocompatible magnetic nanoparticles to print cells into 3D structures more affordably than competing bioprinting tech currently on the market. The BiO Assay represents a sea change in pharmaceutical research, offering better and faster results than have previously been possible.

RBCC formed a biotech subsidiary, Rainbow Biosciences, to market and develop new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Amgen Inc. (NASDAQ: AMGN). In 2012, Rainbow Biosciences acquired an equity interest in n3D.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB: RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit  www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit  www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.



Contact:

Rainbow Coral Corp.
Kimberly Palmer, 850-269-7230
President and CEO
Email Contact




Review Article Be the first to review this article
Featured Video
Editorial
Jeff RoweJeff's MCAD Blogging
by Jeff Rowe
GE Additive’s Big Plans For Metal AM
Jobs
ECAD Designer - Data Connectivity for Delphi at Auburn Hills, MI
Mechanical Engineer II - Requisition ID 090445 for L3 Technologies at New York, NY
Estimator / Bidder for Rulon International at Saint Augustine, FL
Upcoming Events
33rd Annual Coordinate Metrology Society Conference at Snowbird UT - Jul 17 - 21, 2017
EMO Hannover 2017 at Hannover Germany - Sep 18 - 23, 2017
The 30th Annual Integrated Process Excellence Symposium & Training at Wyndham Grand Bonnet Creek Resort Orlando FL - Sep 18 - 20, 2017
Additive Manufacturing Conference 2017 at Knoxville Convention Center 701 Henley Street Knoxville TN - Oct 10 - 12, 2017



Internet Business Systems © 2017 Internet Business Systems, Inc.
595 Millich Dr., Suite 216, Campbell, CA 95008
+1 (408)-337-6870 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering EDACafe - Electronic Design Automation GISCafe - Geographical Information Services TechJobsCafe - Technical Jobs and Resumes ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy Policy Advertise